Plus: Clinical hold lifted on Astellas gene therapy, FDA reviewers scrutinize rezafungin’s benefit and updates from Deciphera, Disc and more

Plus Everest signs licensing deal with Singapore’s EDDC and updates from Vir, AZ, BenevolentAI and more

Martin Shkreli isn’t included in the settlement, his trial to start this month

Preterm birth drug has long been focus of drug pricing, efficacy concerns

House Democrats are starting what is certain to be a sustained effort to reduce U.S. drug prices by targeting a cap on Medicaid drug rebates that manufacturers must pay when price increases exceed

Data dump details FDA’s scramble to approve Ruzurgi as alternative to high-priced Firdapse